Tiziana Life Sciences Ltd (TLSA) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access TLSA Annual Income Statement →
Quarterly income statement trends provide context on Tiziana Life Sciences Ltd's margins, operating leverage, and earnings trajectory.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Q4 2025
0 0 0 (Dec 31 2023)
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Research and Development Expense-10.28
OtherOperating Income Expense63.40
Total operating costs including COS21.13
Operating income / -loss-21.13
Net Interest Expense / -Income0.00
Other loss / -income-2.70
Total costs & expenses18.43
Income & Taxes
Income / -loss before income taxes-18.43
Income after income taxes-18.43
Net income / -loss of other equity0.00
Income / -loss from continuing operations-18.43
Net income / -loss-18.43
Income / -loss to shareholder-18.43
EBIT-18.43
EBITD-18.42
EBITDA-18.42
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Basic shares outstanding (Mill. of Units)0.00
Diluted Net EPS0.00
Diluted average shares (Mill. of Units)0.00
4 historic quarters locked

Sign in to unlock the full Tiziana Life Sciences Ltd income statement history.

About TLSA Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.